THE go al o f o ur s tudy w as to as s es s the ch em o tactic activity for eo s in o p h ils (ECA ) and ne utr op h ils (NCA ) an d h is tam in e r eleas in g activity
Introduction
Bronchial asthma is a chronic inflammatory proce ss, charac te rize d by the influx and acc umulation of eosinophils, ne utrophils, lymphocyte s and monocytes /mac rop hages in the airw ay mucosa. 1 An inc re ased number of eosinophils w as observed in bronchial muc osa and in bronchio-alve olar lavage (BAL) in patie nts w ith seasonal and pere nnial asthma. 2 The e osinophilic influx afte r allerge n provocation is acc ompanie d by the inc rease of eosinophils che motac tic ac tivity (ECA) in BAL. 3, 4 Similarly natural ex posure to allerge n induce s the increase of the ECA in bronchoalve olar lavage and in se rum. 3 Our earlier studies also demonstrated the pre sence of ECA in the se rum of patients w ith atopic asthma as w e ll as che motac tic ac tivity for ne utrophils (NCA ) in nasal lavage in patie nts suffering from p ollinosis. 5, 6 These data sugge st that mechanisms initiate d as a response to alle rgen leading to release of chemotactic molecules, w hich are responsible for the selec tive influx of eosinophils to the lungs.
Mononuclear c ells p lay an imp ortant role in the development of allergic inflammation by the gene rating of cytokines w ith proinflammatory properties, thus participating ac tively in the ge neration of the effector phase of alle rgic inflammation.
7 -1 2 Se veral cytokines, e.g. RANTES or MCP, have eosinophil che motac tic ac tivity and additionally may cause basophil degranulation and re lease histamine. 13 -1 5 Other mononuclear c ell-de rive d cytokines (e .g. IL-8 and MCP-1 ) have NCA and HRA. 16 -1 8 Acting in conc ert w ith othe r chemotactic agents originating from mastoc ytes and basophils (e.g. PAF, LTB4 ) the se cytokines induce the influx of c ells into the site of the alle rgic reaction. Most studies have foc used on the me asurement of the re le ase of clearly de fine d cytokines by MNC and on the e ffec t of the se c ytokine s in isolated biologic al systems. 19 -21 How eve r, activate d inflammatory ce lls release , at the same time or se que ntially, se ve ral mediators, and the ir biological effect is the re sult of complex and not completely understood inte ractions. Thus, me asure ment of biologic al ac tivity of 'c rude' supe rnatants of antigenstimulated ce lls may provide obse rvations more rele vant to in vivo situations, than measurement of a single me diator or a cytokine.
The aim of our study w as to inve stigate the ability of MNC to spontaneous and antigen-induce d gene ration of che motac tic activity for e osinophils and ne utrophils as w ell as HRA in a group of asthmatic patients, allergic to the house dust mite antigen De r p I. The re sults obtaine d in the asthmatic p atie nts w ere compared w ith the control group of healthy individuals.
Materials and Methods

Patients
The study included 22 patie nts (mean age 35 ± 7.19 ye ars; 12 female and 10 me n ) w ith pe rennial atopic bronchial asthma and clinically dominating allergy to house dust mites. All patients had p ositive skin prick te sts w ith De r p I allergen. No patient w as on inhaled oral corticoste roids for at least 2 w ee ks be fore the study. Methylox antins or short-acting antihistamines w ere stoppe d at le ast 72 h be fore obtaining their blood samples. A control, non-atopic group comprise d 11 healthy subjec ts w ithout any complaints conc erning the respiratory trac t and w ith negative skin prick te sts to a battery of inhalant alle rge ns.
MNC isolation and culture
Mononuclear ce lls w ere isolate d w ith Boyüm's me thod. 22 In brie f, 20 ml of heparinize d venous blood w as mix ed w ith PBS in 1: 3 proportion, then care fully stratified on 'Lymphoprep' gradient (Pharmacia ) and ce ntrifuge d at 400 ´g for 20 min. The ring, w hich forme d on the borde rline of the phases, w as carefully collected and rinse d in phosphate buffe r pH 7.4 w ithout Ca + + and Mg + + as w ell as 0.036% glucose so that the number of c ells e qualled 2 ´10
6 ml. Nex t, the ce lls w e re cultured ac cording to The uson's method. 2 3 Culture medium consis ting of PBS w ith Ca + + and Mg + + or 0.036% gluc ose and 0.1% bovine albumin w as used. De r p I allerge n in the conc entration 10 -2 m g /ml (in the asthmatic subje cts ) or PHA mitoge n in conc entration 25 m g /ml (in healthy subjec ts ) w ere added to ce ll susp ension and the samples w ere preinc ubated for 4 h in the inc ubator w ith 5% CO 2 and 95% humidity at 37°C. Then the c ells w ere ce ntrifuge d for 20 min 400 ´g , w ashed tw ic e in PBS w ithout Ca + + and Mg + + , suspe nded in the primary me dium volume and c ultured for 24 h in the same conditions. Ce lls c ulture d in the me dium alone (spontaneous c ulture s ) se rved as a c ontrol. The n the samples w ere c entrifuged for 20 min at 400 ´g , supe rnatants dialyse d in PBS for 24 h and frozen until ECA, NCA and HRA ac tivitie s w ere me asured.
Measurement of ECA and NCA
Granulocytes from a healthy donor, p re viously te ste d for c ells chemotactic activity, w ere isolated using Boyüm's me thod. 22 Chemotax is w as measured by applying modifie d Boyden's method using a 48-w e ll chamber (Ne uroprobe; Be the sda, MD, USA) and Millipore filters PVP-free w ith pore diameter 5 m m and 10 m m thic k. 
Measurement of HRA
To e valuate the supernatants derived HRA the method of Siriganian w as used. 26 Basophils from the he althy donor w ere isolate d as previously described 13 and to 100 m l of the ce ll suspe nsion (2 ´10
6 ce lls /ml), 400 m l of the ex amined supernatant w as added. The sample s w ere inc ubate d at 37°C for 30 min w hile carefully stirre d, and then ce lls w ere coole d rapidly to 4°C and ce ntrifuge d for 8 min (1500 /min, te mperature 4°C). The supe rnatants (containing release d histamine ) and the sedime nts w ere sec ure d by fre ezing. His tamine w as asse ssed w ith the spec trofluorometric method. 2 6 The read-outs (in re lation to the standard c urve for histamine ) w ere c arried out on an LS 50 sp ectrofluorometer (Pe rkin-Elmer ). HRA w as ex pressed as the pe rcentage of the rele ased from basophils histamine acc ording to the follow ing formula: %HRA = His tamine in the basophils supe rnatant ´100
His tamine in the basophils supe rnatant + histamine in the se dime nt Partial purification of the chemotactic activity by gel column chromatography
The approx imate molec ular w eight of the chemotactic activity w as determine d. Supernatants obtaine d from MNC (from thre e asthmatic and three healthy subjec ts ) w ere stratified on a c olumn containing Se phadex gel G-75 (by Pharmacia ) at flow rate of 12 ml/h. The mononucle ar c ell culture supe rnatant fluid w as elute d w ith PBS. Tw o-ml frac tions w ere collec te d and analyse d in duplicate for ECA, NCA or HRA. A kit (Sigma ) for molecular w eight as standard for column chromatography w as used. Prote in c oncentration in each fraction w as measured at absorbenc y 280 nm.
Statistical analysis
The statistic al analysis w as pe rforme d w ith Student's d-te st and t-te st, pre ce de d by e valuation of normality w ith F-te st. In all case s, a P value less than 0.05 w as considere d significant.
Results
ECA release by mononuclear cells from atopic patients
Signific ant ECA w as measured in the supe rnatants of mononucle ar c ells isolate d from 14 out of 22 asthmatic patients and the average chemotactic index for this subgroup [ECA (+ )] w as 3.78 ± 0.49. Supernatants obtained from the re maining eight patie nts not only did not ex press che motactic activity, but clearly inhibited the migration (chemokine sis ) of eosinophils. The average value of the chemotactic index in this group w as 0.25 ± 0.16. This subgroup w as denoted as non-rele asing ECA [ECA (-)].
Stimulation of the mononucle ar ce lls from atopic asthmatic patie nts w ith De r p I antigen did not affe ct the mean ECA for the w hole group (n = 22; before stimulation the me an chemotactic index w as 2.5 ± 0.48; afte r stimulation 2.45 ± 0.69; P > 0.05 ). How e ver in the ECA (+ ) subgroup, antigen stimulation considerably de cre ase d the activity in 10 of 11 patients and the mean ECA index w as 1.98 ± 0.49 (P < 0.05 ). In contrast, in the ECA (-) subgroup, after stimulation w ith antigen, the inc re ase in e osinop hil chemotac tic activity w as revealed in se ve n out of e ight ex amine d patients (the me an value of chemotac tic index inc re ased to 3.73 ± 1.73; P < 0.05 ) (Fig. 1 ) .
ECA release in healthy individuals
The mean ECA in healthy individuals w as similar to me an ECA in atopic patients (P > 0.05 ). In the group of he althy individuals signific ant ECA w as pre sent in six out of 11 ex amine d supernatants [ECA (+ )] and the re maining supe rnatants [ECA (-)], had suppressive effe ct on che mokine sis of eosinophils. The me an index in the ECA (+ ) and ECA (-) subgroups w ere 2.44 ± 0.27 and 0.48 ± 0.22 respective ly (Fig. 2 ) . Stimulation of MNC w ith Der p I antige n did not affe ct ECA generation in c ontrol patients (data not show n ). After stimulation w ith p hytohaemagglutinin (PHA) the me an value of ECA index increase d to 4.13 ± 1.22 for the ECA (+ ) subgroup and 3.19 ± 1.1 for the ECA (-) subgroup (P < 0.05 ) (Fig. 2 ) .
Re le
a s e o f ECA a n d ECIA by m o n o nu cle a r ce lls Mediators
NCA and HRA release from MNC atopic patients
Mononuclear c ells supernatants from all atopic patients c ontained signific ant ne utrophil chemotac tic activity (NCA) but the re w e re no significant differences betw e en the values of che motax is index in the ECA (+ ) or ECA (-) subgroups (me an 2.48 ± 0.27; 2.11 ± 0.22 for both groups re spe ctively ) ( Table 1 ) . Stimulation of MNC w ith Der p I antige n did not affe ct ne utrophil che motac tic activity ne ither in the ECA (+ ) nor ECA (-) groups.
A signific ant HRA w as found in MNC supernatant of 22 asthmatic p atie nts (me an 29.33% ± 1.80 ) w ith no difference betw ee n ECA (+ ) or ECA (-) patients (P > 0.05 ). The re w as an inc rease in the pe rc entage of histamine rele ase from basophils in re sponse to supe rnatants obtaine d from antige n stimulated cells comparing to sp ontane ous culture supe rnatants, how e ver only the increase in the ECA (+ ) group w as significant (P < 0.05 ) ( Table 1 ) .
NCA and HRA in the MNC supernatants of healthy individuals
Mononuclear c ells from the healthy subjec ts generated neutrophil che motac tic activity (NCA) and the me an chemotax is index w as similar to atopic patie nts (P > 0.05 ). There w as no diffe renc e in NCA betw e en Table 1 . Generation of NCA and HRA by mononuclear cells from control non-atopic subjects and from asthmatic patients sensitive to Der p I antigen; *P < 0.05 compared with non-stimulated cells; ‡P < 0.05 compared with ECA (+) subgroup Control non-atopic subjects Asthmatic patients ECA (+ ) and ECA (-) non-atop ic subjects and stimulation of c ells w ith PHA did not affec t NCA. HRA w as present in all supernatants from non-atopic subjec ts (mean 21.34% ± 1.58 ) although w as significantly low er compare d w ith atopic patients (me an 29.52% ± 1.74; P< 0.05 ). After stimulation w ith PHA, a significant inc re ase in HRA w as obse rved only in ECA (-) subjects (Table 1 ) .
Partial purification of chemotactic activity In pooled MNC supernatants from c ontrol subjec ts (Fig. 4 ) , the first peak of ECA w as found in are a corresp onding to molecular w eight above 67 kD. The se cond peak w ith significant ECA w as prese nt in the are a of 14.5 kD and the third peak below 6 kD. Signific ant eosinophil chemokinesis inhibitory ac tivity w as prese nt in fractions w ith molec ular w e ight around 29 kD. HRA w as prese nt in se ve ral frac tions ex tending from 67 kD (48.8% histamine re lease ); 29 kD (30.2% histamine re le ase ) and 14.5 kD (36.08% histamine release ).
Discussion
In this study w e de monstrated, that mononucle ar ce lls isolate d from patients suffe ring from atopic asthma and se nsitized to house dust mite antigen, as w ell as from healthy individuals, ge nerate sp ontane ously ECA. How e ve r, atopic and non-atopic subje cts demonstrated individual variation in ability to release spontaneously che motactic ac tivity for e osinophils. In about one-third of atopic patients and in about half of c ontrol non-atopic subje cts the chemotactic activity w as not observe d. In fac t the supernatants from these ECA (-) subjec ts had strong blocking e ffec t on chemokinesis of eosinophils. Although the release of ECA by MNC w as doc ume nted in several studies 27 ,28 to our know le dge this is the first study reporting the release of inhibitory activity tow ards e osinophil chemokine s. a s e o f ECA a n d ECIA by m o n o nu cle a r ce lls FIG. 4 . Gel column chromatography analysis of ECA and HRA generated by mononuclear cells from healthy subjects (supernatants polled from three subjects).
Re le
Although the mononucle ar c ell-de rived ECA has not bee n w e ll charac te rized it w as doc umented that se veral cytokines (e.g. IL-5, RANTES or Eotax in ) and non-pe ptide mediators (e .g. PAF, LTB4 ) may be involved in this activity. 29 The nature of the eosinophil che motac tic inhibitory activity (ECIA) is more difficult to refer to any spe cific c ytokine or me diator. Ge l column chromatography re ve aled that in atopic patients the major inhibitory activity w as present in fractions w ith molec ular w e ight from 14.5 kD to 6 kD; in non-atopic c ontrols the ECIA w as present in fractions around 29 kD. The se molec ular size s correspond to the molec ular w eights of c ytokines generated by mononucle ar ce lls. Although to our know ledge no spec ific cytokine w ith ECIA has be en reporte d. In addition, in atopic patie nts, inhibitory activity w as also obse rved in low -mole cular-w e ight fractions. This ac tivity may correspond to non-peptide me diators rele ased by MNC, e.g. e icosanoids or histamines release d from basophils, w hich could contaminate MNC p re parations. Accordingly, w e have rec ently reporte d inhibition of eosinophil chemotax is to RANTES after inc ubation of e osinophils w ith histamine .
3 0 Although to our know ledge the pre senc e of eosinophil che mokine sis inhibitory ac tivity has not ye t be en re ported, a gene ration of c ytokine s w ith rec iproc al biologic al effe cts has be en previously desc ribed. Alam e t a l. 31 de sc ribe d a re lease by MNC from asthmatic patients w ith both histamine releasing activity and histamine release inhibitory ac tivity. These activitie s w ere subse que ntly ide ntified as specific c ytokine s; HRA consisted mostly of MCP-1 and RANTES, w hile IL-8 w as c onsidered to be responsible for histamine re le ase inhibitory ac tivity.
In our study ge l chromatography reve aled that MNC supe rnatants contained both chemotactic and eosinophil chemokinesis inhibitory activity in differe nt fractions. Furthermore, stimulation of ECA 'nonreleasing' mononuclear cells in e ithe r a sp ecific (antigen ) or non-spe cific manner (PHA) re sulted in the app earanc e of ECA w ith magnitude similar to that observe d in spontaneous ECA (+ ) supernatants. It may suggest that c ell activation results in gene ration (release ) of chemotactic molec ule s, that ove rw eigh the e ffec t of inhibitory molec ule s. Alte rnative ly, it is possible that the ac tivation of mononucle ar cells may decre ase the release of ECIA, thus allow ing for unopposed activity of mole cules w ith chemotac tic activ ity.
When w e analysed ne utrophil che motac tic and histamines release activity in subgroups of patients, no differences in the spontaneous generation of NCA and HRA w ere obse rved be tw een ECA (+ ) and ECA (-) subjec ts, indicating that the he te rogene ity of the cytokines re le ase could be selec tive, being restricte d only to ECA. How eve r, HRA c ould be differentially modulated by non-spe cific stimulus (PHA) in subgroups non-atopic patients, w ith only ECA (-) subje cts de monstrating an increase in HRA. Ge l c olumn chromatography analysis show e d heteroge neity of molecular w e ight for all ex amine d ac tivities (ECA, NCA and HRA) indicating multifactoral nature of relatively simple in v itro ce llular responses.
It has been doc ume nte d that the ac tivation of eosinophils w ith the cytokines, w hic h are synthe size d and ex creted, by mononuclear ce lls may be vital for the de velop ment of alle rgic inflammation in the respiratory trac t. 31 The immigration of eosinophils into the tissue s is conditione d by the p re sence of Th2-ce ll-derived IL-5, to w hich a significant role in maturing and activation of eosinophils is attribute d. 14 ,1 7 Our study w as not aimed at determining w hich of the know n cytokine is responsible for the eosinophil signalling. We can spe culate how e ve r, that ECA me asure d in che motac tic assay results from the coordinate d ac tivity of a number of che motac tic cytokines w ith both p ro-and anti-chemotactic ac tivity. Our results e mphasize a complicate d nature of alle rgic inflammation, w hich may not be visible, w hen a single me diator or c ellular compone nt is studied. These data also stress the re levance of studying biological activitie s of crude ce lls /tissue s products in addition to analysis of ge neration of w e lldefined me diators. Such an ap proach may allow for the better understanding of complex relations, betw e en the differe nt me diators prese nt in the biological syste m, w here the final biological e ffec t of a single mediator (cytokine ) depe nds on its interactions w ith othe r fac tors.
In c onclusion w e demonstrate d that mononuclear ce lls isolated from the peripheral blood of patients w ith atopic asthma and from healthy individuals generate in v itro , not only e osinophil chemotactic activity, but also eosinophil chemokinesis inhibitory activity. MNC of subjec ts gene rating e osinophil chemokine sis inhibitory ac tivity w ere c apable of producing ECA afte r stimulation w ith antigen or PHA in atopic and c ontrol subje cts re spe ctively.
